Preclinical In Vitro Drug Discovery Contract Research Organization (CRO)
Massachusetts Preclinical Drug Discovery Contract Research Organization
On NextCompany since September 30, 2026 (15 days)
MA area
Business overview
This Massachusetts contract research organization developed assays, screened compounds, and optimized leads for preclinical drug discovery. It serves biotech and pharmaceutical companies in the Northeast using biochemical and cell-based platforms. Recurring and repeat revenue averaged 69.9% during 2022-2025. The listing reports $2,110,926 in gross revenue and $180,515 in EBITDA.
Average gross profit and adjusted EBITDA margins reached 42.8% and 13.1%, respectively, during 2022-2025. The company leases a 5,505-square-foot Massachusetts facility from an unrelated third party. A buyer may assume the lease. Growth opportunities include fuller facility use, outbound marketing, partnerships, and geographic expansion.
Who is a good fit for this business
- Biotech and pharmaceutical acquirers seeking preclinical assay development, screening, and lead optimization capacity in the Northeast.
- Laboratory operators seeking growth through fuller facility use, outbound marketing, partnerships, or geographic expansion.
Details
- Reason for selling
- The founder & CEO is seeking to financially de-risk.
- Real estate
- Leased
Frequently Asked Questions
The company develops assays, screens compounds, and optimizes leads using biochemical and cell-based platforms. It serves biotech and pharmaceutical companies in the Northeast.
The listing reports $2,110,926 in gross revenue and $180,515 in EBITDA. Recurring and repeat revenue averaged 69.9% during 2022-2025.
The business averaged a 42.8% gross profit margin during 2022-2025. Its adjusted EBITDA margin averaged 13.1% over that period.
The company leases a 5,505-square-foot facility in Massachusetts from an unrelated third party. The lease permits a buyer to assume it.
The founder and CEO seeks to reduce financial risk. The listing identifies fuller facility use, outbound marketing, partnerships, and geographic expansion as growth opportunities.